# Medeligo — user reviews

> 5 indexed App Store user reviews of Medeligo by LiveMed Media Ltd., rated 5.00/5 from 9 ratings.

- Source: https://appshunter.io/ios/app/medeligo/id1000247107/reviews
- App overview in markdown: https://appshunter.io/ios/app/medeligo/id1000247107.md
- Rating breakdown: 5★ 9 · 4★ 0 · 3★ 0 · 2★ 0 · 1★ 0

## Most critical reviews (5 lowest-rated)

### 5/5 — Highly Recommend

*2024-03-12, version 1.5.4*

Awesome APP, provides clinically relevant information at your fingertips.

### 5/5 — Highly recommend!

*2020-11-11, version 1.4.9*

So glad I found this app. How did I not know about it? It’s easy to use and provides fast access to information that I otherwise might not have time to find.

### 5/5 — Wonderful application

*2016-11-28, version 1.0.5*

Medeligo is an great application. It offers an easy to use interface to engage in an extensive search engine and database. The use for immediate access to specific question regarding specific pathologies makes this application particularly useful. I would recommend this product for anyone who engages in clinical or basic science oncology research.

### 5/5 — Pediatric Neurosurgery

*2016-11-28, version 1.0.5*

I have been using the app for about 6 months and have found it to be very useful. It makes valuable information on pediatric brain tumors easily available. I've also had the opportunity to share it with my residents who use it to read about upcoming cases or consults. I definitely recommend the app.

### 5/5 — Precise, reliable, essential!

*2016-11-22, version 1.0.5*

The Medeligo app is beyond anything I have used before. I used the app on the fly during my neurosurgical sub-internships nearly everyday. It’s a great way to look up information before cases and patient encounters and is an amazing resource for general study purposes. The app has become an essential for me, it’s truly helpful!

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-11.*